Antibacterial properties of compounds isolated from Carpobrotus edulis

International Journal of Antimicrobial Agents

Volumn 37, Issue 5, 2011, Pages 438-444

  Martins, A ^a,b   Vasas, A ^b   Viveiros, M ^a,c   Molnar J ^b,c   Hohmann, J ^b   Amaral, L ^a,c  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSITY OF SZEGED   (Hungary)

^c BM0701 Cost Action (ATENS) of the European Commission/European Science Foundation   (Greece)

Author keywords

Aizoaceae; Carpobrotus edulis; Efflux pump inhibition; Efflux pumps; Enterococcus faecalis; Escherichia coli; Isolated compounds; Multidrug resistance; Mycobacterium tuberculosis; Salmonella enterica serotype Enteritidis; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; BETA AMYRIN; CATECHIN; CIPROFLOXACIN; EPICATECHIN; GALACTOSYLDIACYLGLYCEROL; METICILLIN; OLEANOLIC ACID; OXACILLIN; TETRACYCLINE; TRITERPENE; UVAOL;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CARPOBROTUS EDULIS; CONTROLLED STUDY; DRUG ISOLATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLANT; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; STAPHYLOCOCCUS AUREUS;

AIZOACEAE; ANTI-BACTERIAL AGENTS; BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; OLEANOLIC ACID; PLANT EXTRACTS; TRITERPENES;

EID: 79953836705     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.01.016     Document Type: Article

References (47)

1. Mathabe MC, Nikolova RV, Lall N, Nyazema NZ. Antibacterial activities of medicinal plants used for treatment of diarrhoea in Limpopo Province, South Africa. J Ethnopharmacol 2006;105:286-93.
2. Scott G, Hewett ML. Pioneers in ethnopharmacology: The Dutch East India Company (VOC) at the Cape from 1650 to 1800. J Ethnopharmacol 2008;115:339-60.
3. Springfield EP, Amabeoku G, Weitz F, Mabusela W, Johnson Q. An assessment of two Carpobrotus species extracts as potential antimicrobial agents. Phytomedicine 2003;10:434-9. (Pubitemid 36745168)
4. Thring TSA, Weitz FM. Medicinal plant use in the Bredasdorp/Elim region of the Southern Overberg in the Western Cape Province of South Africa. J Ethnopharmacol 2006;103:261-75. (Pubitemid 41796927)
5. Watt E, Pretorius JC. Purification and identification of active antibacterial components in Carpobrotus edulis. J Ethnopharmacol 2001;76:87-91. (Pubitemid 32510736)
6. Ordway D, Hohmann J, Viveiros M, Viveiros A, Molnar J, Leandro C, et al. Carpobrotus edulis methanol extract inhibits the MDR efflux pumps, enhances killing of phagocytosed S. aureus and promotes immune modulation. Phytother Res 2003;15:512-9. (Pubitemid 36605904)
7. Suehs CM, Affre L, Médail F. Invasion dynamics of two alien Carpobrotus (Aizoaceae) taxa on a Mediterranean island: I. Genetic diversity and introgression. Heredity 2004;92:31-40.
8. Underwood EC, Ustin SL, Ramirez CM. A comparison of spatial and spectral image resolutions for mapping invasive plants in coastal California. Environ Manage 2007;39:63-83. (Pubitemid 44915466)
9. Martins M, Ordway D, Kristiansen M, Viveiros M, Leandro C, Molnar J, et al. Inhibition of the Carpobrotus edulis methanol extract on the growth of phagocytosed multidrug-resistant Mycobacterium tuberculosis and methicillin-resistant Staphylococcus aureus. Fitoterapia 2005;76:96-9. (Pubitemid 40139009)
10. Martins A, Vasas A, Schelz Z, Viveiros M, Molnár J, Hohmann J, et al. Constituents of Carpobrotus edulis inhibit P-glycoprotein of mdr1-transfected mouse lymphoma cells. Anticancer Res 2010;30:829-35.
11. Korish AA, Arafah MM. Catechin combined with vitamins C and E ameliorates insulin resistance (IR) and atherosclerotic changes in aged rats with chronic renal failure (CRF). Arch Gerontol Geriatr 2008;46:25-39. (Pubitemid 350166580)
12. Kawai Y, Tanaka H, Murota K, Naito M, Terao J. (-)-Epicatechin gallate accumulates in foamy macrophages in human atherosclerotic aorta: implication in the anti-atherosclerotic actions of tea catechins. Biochem Biophys Res Commun 2008;374:527-32.
13. Howells LM, Moiseeva EP, Neal CP, Foreman BE, Andreadi CK, Sun YY, et al. Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 2007;28:1274-304. (Pubitemid 47366687)
14. Zessner H, Pan L, Will F, Klimo K, Knauft J, Niewöhner R, et al. Fractionation of polyphenol-enriched apple juice extracts to identify constituents with cancer chemopreventive potential. Mol Nutr Food Res 2008;52(Suppl. 1):S28-44.
15. Souccar C, Cysneiros RM, Tanae MM, Torres LM, Lima-Landman MT, Lapa AJ. Inhibition of gastric acid secretion by a standardized aqueous extract of Cecropia glaziovii Sneth and underlying mechanism. Phytomedicine 2008;15:462-9.
16. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999;12:564-82. (Pubitemid 29484747)
17. Pfyffer GE, Bonato DA, Ebrahimzadeh A, Gross W, Hotaling J, Kornblum J, et al. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol 1999;37:3179-86. (Pubitemid 29455202)
18. Kuete V, Metuno R, Ngameni B, Mbaveng AT, Ngandeu F, Bezabih M, et al. Antimicrobial activity of the methanolic extracts and compounds from Treculia africana and Treculia acuminata (Moraceae). S Afr J Bot 2008;74:111-5. (Pubitemid 350266936)
19. Lechner D, Gibbons S, Bucar F. Modulation of isoniazid susceptibility by flavonoids in Mycobacterium. Phytochem Lett 2008;1:71-5.
20. Stavri M, Piddock LJV, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 2007;59:1247-60. (Pubitemid 47073343)
21. Copp BR, Pearce AN. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat Prod Rep 2007;24:278-97. (Pubitemid 46496562)
22. Gu JQ, Wang Y, Franzblau SG, Montenegro G, Yang D, Timmermann BN. Antitubercular constituents of Valeriana laxiflora. Planta Med 2004;70:509-14. (Pubitemid 38887906)
23. Jimenez-Arellanes A, Meckes M, Torres J, Luna-Herrera J. Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae). J Ethnopharmacol 2007;111:202-5. (Pubitemid 46528067)
24. Woldemichael GM, Franzblau SG, Zhang F, Wang Y, Timmermann BN. Inhibitory effect of sterols from Ruprechtia triflora and diterpenes from Calceolaria pinnifolia on the growth of Mycobacterium tuberculosis. Planta Med 2003;69:628-31. (Pubitemid 37041058)
25. Woldemichael GM, Wächter G, Singh MP, Maiese WM, Timmermann BN. Antibacterial diterpenes from Calceolaria pinifolia. J Nat Prod 2003;66:242-6. (Pubitemid 36278237)
26. Farina C, Pinza M, Pifferi G. Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids. Farmaco 1998;53:22-32. (Pubitemid 29099635)
27. Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995;49:57-68. (Pubitemid 26010740)
28. Martins A, Couto I, Aagaard L, Martins M, Viveiros M, Kristiansen JE, et al. Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in amultidrug-resistant phenotype. Int J Antimicrob Agents 2007;29:302-5. (Pubitemid 46240753)
29. Okusu H, Ma D, Nikaido H. AcrAB efflux pump plays amajor role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants. J Bacteriol 1996;178:306-8. (Pubitemid 26006095)
30. Viveiros M, Jesus A, Brito M, Leandro C, Martins M, Ordway D, et al. Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes. Antimicrob Agents Chemother 2005;49:3578-82. (Pubitemid 41060625)
31. O'Regan E, Quinn T, Pagès JM, McCusker M, Piddock L, Fanning S. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar Enteritidis: involvement of ramA and other global regulators. Antimicrob Agents Chemother 2009;53:1080-7.
32. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Document M100-S17. Wayne, PA: CLSI; 2007.
33. Martins M, Schelz Z, Martins A, Molnar J, Hajös G, Riedl Z, et al. In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis. Int J Antimicrob Agents 2007;29:338-40.
34. Viveiros M, Amaral L. Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines. Int J Antimicrob Agents 2001;17:225-8. (Pubitemid 32229901)
35. Viveiros M, Martins A, Paixão L, Rodrigues L, Martins M, Couto I, et al. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents 2008;31:458-62.
36. Martins A, Spengler G, Rodrigues L, Viveiros M, Ramos J, Martins M, et al. pH modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon. PLoS One 2009;4:e6656.
37. Gibbons S. Phytochemicals for bacterial resistance-strengths, weaknesses and opportunities. Planta Medica 2008;74:594-602. (Pubitemid 351846775)
38. Hemaiswarya S, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008;15:639-52.
39. Hussain Z, Stoakes L, Massey V, Diagre D, Fitzgerald V, El Sayed S, et al. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J Clin Microbiol 2000;38:752-4. (Pubitemid 30082676)
40. Klitgaard JK, Skov MN, Kallipolitis BH, Kolmos HJ. Reversal of methicillin resistance in Staphylococcus aureus by thioridazine. J Antimicrob Chemother 2008;62:1215-21.
41. Severin A, Tabei K, Tenover F, Chung M, Clarke N, Tomasz A. High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex. J Biol Chem 2004;279:3398-407. (Pubitemid 38140576)
42. Adhikari RP, Scales GC, Kobayashi K, Smith JMB, Berger-Bächi B, Cook GM. Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus. J Antimicrob Chemother 2004;54:360-3. (Pubitemid 39177454)
43. Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M, et al. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One 2007;2:e365.
44. Pagès J-M, Amaral L. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta 2009;1794:826-33.
45. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989;58:137-71. (Pubitemid 19172967)
46. Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakrai Y. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res 1984;44:4303-7. (Pubitemid 14008739)
47. Somova LI, Shode FO, Mipando M. Cardiotonic and antidysrhythmic effects of oleanolic and ursolic acids, methyl maslinate and uvaol. Phytomedicine 2004;11:121-9. (Pubitemid 38314051)